Benzo[a]pyrene-3,6-dione inhibited VEGF expression through inducing HIF-1alpha degradation

Biochem Biophys Res Commun. 2007 Jun 1;357(2):517-23. doi: 10.1016/j.bbrc.2007.03.178. Epub 2007 Apr 9.

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenesis inducer for tumor growth and angiogenesis. Benzo[a]pyrene (BaP) belongs to polycyclic aromatic hydrocarbons (PAHs) and is known to cause carcinogenesis. But the effects of BaP and its metabolites on VEGF and HIF-1 expression remain to be elucidated. In this study, we found benzo[a]pyrene-3,6-dione (BPQ), but not BaP and benzo[a]pyrene-7,8-diol-9,10-epoxide (BPDE) inhibited VEGF expression in a dose-dependent manner. BPQ inhibited VEGF transcriptional activation through hypoxia-inducible factor 1 (HIF-1) binding site. BPQ specifically decreased HIF-1alpha, but not HIF-1beta subunit expression in A549 cells. We found that BPQ did not inhibit HIF-1alpha mRNA level, but inhibited its protein expression in a proteasome-dependent manner. To further clarify the mechanism of BPQ in regulating HIF-1alpha stability, we found that BPQ inhibited HIF-1alpha protein expression by the increase of the proteasome-dependent degradation, and by the disruption of HIF-1alpha and Hsp90 association.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism*
  • Benzopyrenes / administration & dosage*
  • Cell Line
  • Dose-Response Relationship, Drug
  • Gene Expression / drug effects*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism*
  • Kidney / drug effects
  • Kidney / metabolism*
  • Proteasome Endopeptidase Complex / drug effects
  • Proteasome Endopeptidase Complex / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Benzopyrenes
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Vascular Endothelial Growth Factor A
  • Proteasome Endopeptidase Complex